Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Arrow Financial
AROW
$723M
| $8.23M | ﹤0.01% |
245,144
-9,469
| -4% | -$298K |
|
|
WLL
2302
DELISTED
Whiting Petroleum Corporation
WLL
| $8.21M | ﹤0.01% |
14,918
-95
| -0.6% | -$45.9K |
|
2303
Tredegar Corp
TG
$278M
| $8.21M | ﹤0.01% |
367,364
-5,458
| -1% | -$115K |
|
2304
Bank of Marin Bancorp
BMRC
$462M
| $8.2M | ﹤0.01% |
182,052
-4,234
| -2% | -$187K |
|
|
CHK
2305
DELISTED
Chesapeake Energy Corporation
CHK
| $8.2M | ﹤0.01% |
49,640
+2,704
| +6% | +$544K |
|
|
HSII
2306
DELISTED
Heidrick & Struggles
HSII
| $8.19M | ﹤0.01% |
251,998
-1,677
| -0.7% | -$49.4K |
|
|
HMHC
2307
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $8.16M | ﹤0.01% |
1,305,222
-29,291
| -2% | -$171K |
|
2308
Talos Energy
TALO
$2.58B
| $8.15M | ﹤0.01% |
270,357
-1,004
| -0.4% | -$23.4K |
|
2309
Prothena Corp
PRTA
$466M
| $8.15M | ﹤0.01% |
514,866
+20,816
| +4% | +$223K |
|
2310
Rocket Pharmaceuticals
RCKT
$367M
| $8.15M | ﹤0.01% |
357,940
-11,796
| -3% | -$197K |
|
2311
York Water
YORW
$536M
| $8.14M | ﹤0.01% |
176,450
-4,802
| -3% | -$211K |
|
2312
Northern Oil and Gas
NOG
$2.61B
| $8.13M | ﹤0.01% |
347,546
+154
| +0% | +$3.05K |
|
2313
DXP Enterprises
DXPE
$3B
| $8.13M | ﹤0.01% |
204,265
+177
| +0.1% | +$6.6K |
|
2314
Gossamer Bio
GOSS
$83.3M
| $8.12M | ﹤0.01% |
519,690
+11,086
| +2% | +$223K |
|
2315
Cytokinetics
CYTK
$10.2B
| $8.12M | ﹤0.01% |
765,408
-25,210
| -3% | -$259K |
|
|
UCFC
2316
DELISTED
United Community Financial Corp
UCFC
| $8.1M | ﹤0.01% |
694,900
-11,051
| -2% | -$123K |
|
2317
CEVA Inc
CEVA
$855M
| $8.09M | ﹤0.01% |
300,096
-6,727
| -2% | -$184K |
|
2318
WisdomTree
WT
$3.44B
| $8.08M | ﹤0.01% |
1,669,689
-2,632
| -0.2% | -$13.1K |
|
|
FLIC
2319
DELISTED
First of Long Island Corp
FLIC
| $8.07M | ﹤0.01% |
321,647
-7,787
| -2% | -$186K |
|
2320
Ardmore Shipping
ASC
$707M
| $8.06M | ﹤0.01% |
890,217
+4,896
| +0.6% | +$40.7K |
|
|
EIDX
2321
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $8.03M | ﹤0.01% |
139,935
-3,618
| -3% | -$179K |
|
2322
Peoples Bancorp
PEBO
$1.49B
| $8.03M | ﹤0.01% |
231,586
-7,326
| -3% | -$240K |
|
|
EGRX
2323
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $8.02M | ﹤0.01% |
133,505
-3,711
| -3% | -$221K |
|
|
CUTR
2324
DELISTED
Cutera, Inc.
CUTR
| $7.94M | ﹤0.01% |
221,708
-1,910
| -0.9% | -$64.5K |
|
|
BNFT
2325
DELISTED
Benefitfocus, Inc.
BNFT
| $7.94M | ﹤0.01% |
361,817
-11,675
| -3% | -$264K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.